In this video, moderator Dr. Gregory A. Roth and expert panelists provide analysis on: The most prevalent modifiable risk factors in North America, the implications of these findings on clinical practice, how clinicians can address modifiable risks with patients, and considerations for health policy.
Dr. Tomislav Meštrović, IHME and the University North (Croatia) discusses antimicrobial resistance.
Sasha Aravkin, Adjunct Associate Professor and Director of Mathematical Sciences, and Peng Zheng, Assistant Professor, Department of Health Metrics Sciences discuss methodology.
Postdoctoral scholar Christian Razo discusses the burden of disease attributable to high LDL-cholesterol as part of the Health Metrics Sciences lecture series.
Professor Bobby Reiner, MS, PhD, provides an update of the IHME COVID-19 model.
This session, presented by Awoke Misganaw Temesgen, is part of the Health Metrics Sciences lecture series.
Join us in celebrating the accomplishments of 2021 Roux Prize winner Dr. Zulfiqar Bhutta and congratulating the winner of the GBD Emerging Researcher Award Dr. Leopold Aminde.
Maria de Fatima Marinho de Souza presents on verbal autopsy in Brazil as part of the Health Metrics Sciences lecture series.
In this seminar Drs. Abraham Flaxman and Bernardo Hernández Prado present and discuss the development of methods to analyze causes of death based on verbal autopsy information.
Jeff Stanaway, Assistant Professor, Department of Health Metrics Sciences discusses blood lead and mortality risk.
Michael Brauer, Affiliate Professor, Department of Health Metrics Sciences explores the effects of wildfire smoke on health.
Assistant Professor Katrin Burkart discusses estimating the present and future burden of disease attributable to temperature, as part of the Health Metrics Sciences lecture series.
Professor Rafael Lozano presents on health systems research as part of the Health Metrics Sciences lecture series.
Research Professor Marcia Weaver presents on cause-specific spending per disability-adjusted life-year averted from 1996 to 2016, as part of the Health Metrics Sciences lecture series.
Associate Professor Joseph Dieleman discusses COVID-19 and pandemic preparedness, as part of the Health Metrics Sciences lecture series.
For this iteration of the Health Metrics Sciences lecture series, Professor Christopher J. L. Murray and Associate Professor Haidong Wang explore estimating global total COVID-19 mortality.
Professor David Pigott presents on COVID-19 modeling as part of the Health Metrics Sciences lecture series.
Professor Bobby Reiner, MS, PhD, presents the inaugural lecture of the Department of Health Metrics Sciences lecture series.
This webinar is designed primarily for researchers and others interested in more technical information on the methods used to map child growth failure as part of the GBD study.
Despite the trillions of dollars invested into health care annually, we rarely collect systematically the end results of care – outcomes. Lacking outcome data, providers are unable to learn how good they are compared to their peers and where they can improve. This general ignorance also affects patients and payers: patients are unable to select providers who can best treat their condition, and payment is based on activity rather than results.
Overdiagnosis occurs when a tumor is detected by screening but, in the absence of screening, that tumor would never have become symptomatic within the lifetime of the patient. Thus, an overdiagnosed tumor is a true extra diagnosis due solely to the existence of the screening test. Patients who are overdiagnosed cannot, by definition, be helped by the diagnosis, but they can be harmed, particularly if they are treated.
Censuses and surveys have been the primary sources of information on mobility and migration. However, concerns with these data include sample size, detail, accuracy, and expense.
Adolescents and young adults make up over a quarter of the global population. They can also be considered the most pervasively neglected group in global health. Yet a quiet revolution is now bringing a recognition that adolescents are central in almost every major challenge in global health. Bringing greater visibility to adolescents and their health has been an important facet of that recognition.
Much of what we take for granted in health care starts as a study published in a scientific journal. Studies can be complex, highly specific, and full of caveats, and yet, in order for them to be actionable, they need to be translated into real-world application.